OSBPL1A: A Potential Drug Target for Neurological Disorders (G114876)

Target Name: OSBPL1A

NCBI ID: G114876

OSBPL1A

OSBPL1A: A Potential Drug Target for Neurological Disorders

OSBPL1A (Oxidative stress-induced brain-derived neurotrophic factor-like 1A) is a protein that is expressed in various tissues of the body, including brain, heart, and kidneys. It is a member of the family of transmembrane proteins, which means that it spans the cell membrane and is associated with various cellular processes. OSBPL1A has been identified as a potential drug target or biomarker for various neurological and psychiatric disorders, including neurodegenerative diseases, neuropsychiatric disorders, and autoimmune diseases.

The OSBPL1A gene

OSBPL1A is a gene that encodes a protein with 156 amino acid residues. The protein has a molecular weight of 19.9 kDa and a calculated pI of 4.97. It is a monomer and has a linear structure with a single transmembrane region. The protein is expressed in various tissues of the body, including brain, heart, and kidneys.

The OSBPL1A protein

The OSBPL1A protein is involved in various cellular processes, including inflammation, stress response, and neurotrophic factor signaling. It is a potent modulator of cell stress responses and has been shown to play a role in the development and progression of various neurological and psychiatric disorders.

One of the most significant functions of OSBPL1A is its ability to modulate the cellular response to oxidative stress. Oxidative stress is a highly pro-inflammatory state that can damage cellular components and contribute to the development of various diseases, including neurodegenerative disorders. OSBPL1A has been shown to regulate the expression of genes involved in the cellular response to oxidative stress, including those involved in inflammation, stress response, and neurotrophic factor signaling.

In addition to its role in modulating cellular stress responses, OSBPL1A is also involved in the regulation of cellular adhesion. Adhesion is the process by which cells stick together and form tissues. OSBPL1A has been shown to play a role in the regulation of cell-cell adhesion and has been implicated in the development of various psychiatric disorders.

OSBPL1A as a drug target

The potential use of OSBPL1A as a drug target or biomarker makes it an attractive target for researchers to investigate the underlying mechanisms of various neurological and psychiatric disorders.

One potential mechanism by which OSBPL1A could be targeted as a drug is its ability to modulate the cellular response to oxidative stress. Oxidative stress has been implicated in the development and progression of various neurodegenerative disorders, including Alzheimer's disease, Parkinson's disease, and Huntington's disease. By targeting OSBPL1A, researchers may be able to develop new treatments for these disorders.

Another potential mechanism by which OSBPL1A could be targeted as a drug is its role in the regulation of cell adhesion. Cell-cell adhesion has been implicated in the development of various psychiatric disorders, including depression, anxiety, and schizophrenia. By targeting OSBPL1A, researchers may be able to develop new treatments for these disorders.

Competitive analysis

There are currently no known drugs that are specifically targeting OSBPL1A. However, there are several drugs that are known to target proteins that are involved in similar functions, such as S100尾, PDGF-尾, and NF-kappa-B. These drugs have been shown to have neuroprotective effects and may be potential candidates for targeting OSBPL1A.

Conclusion

OSBPL1A is a protein that is expressed in various tissues of the body and is involved in various cellular processes. It has been identified as a potential drug target or biomarker for various neurological and psychiatric disorders, including neurodegenerative diseases, neuropsychiatric disorders, and autoimmune diseases. Further research is needed to understand the full function and potential

Protein Name: Oxysterol Binding Protein Like 1A

Functions: Binds phospholipids; exhibits strong binding to phosphatidic acid and weak binding to phosphatidylinositol 3-phosphate (By similarity). Stabilizes GTP-bound RAB7A on late endosomes/lysosomes and alters functional properties of late endocytic compartments via its interaction with RAB7A (PubMed:16176980). Binds 25-hydroxycholesterol and cholesterol (PubMed:17428193)

The "OSBPL1A Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about OSBPL1A comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets